Bottom line
What is DCEMX's expense ratio?
DCEMX's expense ratio is 2.21%, or about $221 a year on every $10,000 invested. That is more expensive than 99% of emerging markets funds we track (median 1.02%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Feb 27, 2026
DCEMX fee table
| Net expense ratio | 2.21% |
|---|---|
| Gross expense ratio | 2.21% |
| Management fee | 0.77% |
| 12b-1 (distribution) fee | 1% |
| Acquired fund fees | 0.02% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Feb 27, 2026
What DCEMX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| DCEMX | $224 | $691 | $1,185 | $2,544 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 2.21% expense ratio costs roughly $110,300 in lost growth, versus about $56,400 for the median emerging markets fund (1.02%).
Cheaper alternatives to DCEMX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
| Fund | Expense ratio | Saves per year | Saves over 20 yrs* | Overlap |
|---|---|---|---|---|
| MXENX T. Rowe Price | 0.91% | $130 | $5,948 | 60% |
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.